Tag: narrow therapeutic index
Identifying Problem Generics: When Pharmacists Should Flag Issues
Jul, 9 2026Learn when pharmacists should flag problematic generic drugs. Explore risks with NTI meds, bioequivalence gaps, and practical steps to ensure patient safety.
READ MORE
Phenytoin and Generics: Therapeutic Drug Monitoring Requirements
Jun, 9 2026Explore the critical TDM requirements for phenytoin generics. Learn why switching formulations risks toxicity due to non-linear kinetics, how to interpret free vs. total levels, and best practices for safe patient monitoring.
READ MORE
Bridging Studies for NTI Generics: Ensuring Safety and Efficacy in Critical Medications
Jan, 29 2026Bridging studies for NTI generics ensure that life-critical medications like warfarin and levothyroxine are as safe and effective as their brand-name versions. These specialized tests demand tighter bioequivalence standards and complex study designs to protect patients.
READ MORE